In Vitro Diagnostics Quality Control Market to Grow with a CAGR of 1.54% through 2028
Rise of Point-of-Care (POC) Testing is expected to
drive the Global In Vitro Diagnostics Quality Control Market growth in the
forecast period, 2024-2028.
According to TechSci Research report, “In Vitro
Diagnostics Quality Control Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global In
Vitro Diagnostics Quality Control Market stood at USD 988.02 million in 2022
and is anticipated to grow with a CAGR of 1.54% in the forecast period,
2024-2028. In vitro diagnostics (IVD) quality control plays a
pivotal role in ensuring the reliability and accuracy of diagnostic tests
conducted in clinical laboratories. As the healthcare industry continues to
evolve and advance, the Global In Vitro Diagnostics Quality Control Market is
experiencing robust growth. One of the most significant drivers behind the growth
of the IVD quality control market is the escalating global prevalence of
chronic diseases. Conditions such as diabetes, cardiovascular diseases, cancer,
and infectious diseases are on the rise. These ailments often require regular
diagnostic testing to monitor disease progression, treatment efficacy, and
early detection. To ensure patient safety and effective disease management,
healthcare providers must rely on accurate and precise diagnostic results, thus
fueling the demand for quality control solutions to maintain the integrity of
these tests.
The world's population is aging at an unprecedented
rate, especially in developed regions. The elderly are more prone to various
health issues, necessitating frequent diagnostic tests and monitoring. Elderly
individuals typically have complex healthcare needs, and reliable diagnostic
results are crucial for their well-being. The increased demand for diagnostic
testing in this demographic further underscores the importance of quality
control to ensure that diagnostic results are accurate, consistent, and reliable.
The continuous evolution and advancement of diagnostic technologies have played
a pivotal role in the growth of the IVD quality control market. Modern
diagnostic instruments and methodologies offer higher sensitivity, specificity,
and automation. However, these advancements also introduce greater complexity,
making it essential to validate and control the performance of these
technologies. Quality control materials and software are indispensable in
ensuring that these innovative diagnostic tools maintain their accuracy and
precision, which is critical for making informed clinical decisions.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global In Vitro Diagnostics Quality Control Market”
The Global In Vitro Diagnostics Quality Control Market
is segmented into Type, Product, Application, End-use, Regional Distribution,
And Company.
Based on the Type, Quality Control emerged as the dominant segment
in the global market for Global In Vitro Diagnostics Quality Control Market in
2022. Regulatory bodies worldwide have established stringent quality standards
for diagnostic laboratories and manufacturers. Compliance with these
regulations is not optional but mandatory. Quality control is a foundational
requirement for meeting these standards, and failure to comply can result in
severe consequences, including product recalls and legal penalties. This
regulatory compliance is a significant driver of demand for quality control in
the IVD market. Accurate diagnostic results lead to better healthcare outcomes. Quality
control is not just about meeting regulatory requirements but is also central
to the broader goal of enhancing healthcare quality. Healthcare institutions
and professionals understand that the accuracy and reliability of diagnostic
tests are critical to delivering optimal patient care.
Based on the Application, Clinical
Chemistry emerged as the dominant segment in the global market for Global In
Vitro Diagnostics Quality Control Market in 2022. clinical chemistry tests are
essential for diagnosing and monitoring a wide range of diseases, including
diabetes, cardiovascular diseases, liver disorders, and kidney diseases. The
accurate and reliable results of these tests are crucial for effective disease
management and timely intervention. Quality control measures ensure the
precision and consistency of clinical chemistry test results, which is
paramount in patient care. The increasing prevalence of chronic
diseases, such as diabetes and cardiovascular conditions, drives the demand for
clinical chemistry tests. These conditions require ongoing monitoring,
contributing to the high frequency of clinical chemistry testing. Quality
control is instrumental in maintaining the accuracy and reliability of these
tests for chronic disease management.
Based on the End-use,
Hospitals & Clinics emerged as the dominant segment in the global market
for Global In Vitro Diagnostics Quality Control Market in 2022. Hospitals
and clinics perform a significant portion of diagnostic tests globally. They
serve as primary points of healthcare delivery, where patients receive a wide
range of medical services, including diagnostic testing. The sheer volume of
tests conducted in these settings leads to a consistent and substantial demand
for quality control materials and services. Hospitals and clinics offer a
comprehensive array of medical services, necessitating a diverse range of
diagnostic tests. From routine health screenings to complex disease diagnosis,
these healthcare facilities provide a variety of testing services. This
diversity contributes to the high demand for quality control across different
diagnostic disciplines.
North America emerged as the dominant
player in the global In Vitro Diagnostics Quality Control Market in 2022,
holding the largest market share. North American healthcare professionals and
institutions are well-aware of the importance of quality control in diagnostic
testing. They prioritize patient safety and the reliability of diagnostic
results, leading to a consistent demand for quality control solutions. North
America boasts a well-developed and advanced healthcare infrastructure, with a
high concentration of clinical laboratories, hospitals, and diagnostic
facilities. This infrastructure is equipped with state-of-the-art diagnostic
technologies and equipment, which require quality control measures to ensure
their accuracy and reliability.
Major companies operating in Global In Vitro
Diagnostics Quality Control Market are:
- F. Hoffmann-La Roche Ltd
- Alere, Inc.
- Abbott Laboratories Inc.
- Hologic, Inc. (Gen-Probe)
- Qiagen N.V.
- Bio-Rad Laboratories, Inc.
- Quidel Corp.
- bioMerieux, Inc.
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The Global In
Vitro Diagnostics Quality Control Market is poised for significant growth in
the coming years. The rising prevalence of chronic diseases, the aging global
population, and the demand for accurate and reliable diagnostic testing will
continue to fuel the need for robust quality control solutions. Advancements in
diagnostic technologies, including molecular diagnostics and genetic testing,
are increasing the complexity of testing procedures, necessitating more
sophisticated quality control measures. Moreover, the emphasis on patient
safety, regulatory compliance, and the growing awareness of the critical role
quality control plays in healthcare will further boost the market.” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“In Vitro Diagnostics Quality Control Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
Segmented By Type (Quality Controls, Data Management Solutions, Quality
Assurance Services), By Application (Immunoassay, Haematology, Clinical
Chemistry, Molecular Diagnostics, Coagulation, Microbiology, Others), By
End-use (Hospitals & Clinics, Ambulatory Surgical Centers, Others) Region
and Competition”, has evaluated the future growth potential of Global
In Vitro Diagnostics Quality Control Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global In Vitro Diagnostics Quality Control Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel:
+13322586602
Email:
[email protected]
Website:
www.techsciresearch.com